These data indicate that IFNβ produced by activated CD4+ T cells increases the ability of cDC1s to cross-present antigens and cross-prime a CTL response, particularly in a setting where the antigen source for cDC1s is dead tumor cells. This evidence concerns the gene CD4 and neoplasm.